Showing results (351-360 of 580) with videos related to
Sort By:
Pageof 58
Leukemia|April 1, 1997
Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reactionA Hochhaus, F Lin, A Reiter, et al.Leukemia|November 28, 2002
Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugsA J Tipping, F X Mahon, G Zafirides, et al.Journal of the American College of Surgeons|October 10, 2025
Discordance of Perceptions and Experiences of Trauma Surgeons and Their FamiliesJennifer L Hartwell, Shilpa Sachdeva, Steven Lassen, et al.Cytokine|March 17, 1998
Interleukin 3 (IL-3), but not stem cell factor (SCF) increases self-renewal by human erythroid burst-forming units (BFU-E) in vitroJ L Lewis, S B Marley, N M Blackett, et al.Leukemia|November 1, 1994
No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukaemia blast crisisH Silly, A Chase, K I Mills, et al.British Journal of Haematology|October 1, 1978
Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformationJ M Goldman, K H Th'ng, D S Park, et al.Transplantation|May 1, 1992
Evidence that umbilical cord blood contains a higher frequency of HLA class II-specific alloreactive T cells than adult peripheral blood. A limiting dilution analysisS J Deacock, A P Schwarer, J Bridge, et al.British Journal of Haematology|December 3, 1999
Enhanced retroviral gene transfer into CML and normal bone marrow, and CML and mobilized peripheral blood CD34+ cells using the recombinant fibronectin fragment CH-296E Garrett, M I Garin, A R Miller, et al.Tissue Antigens|August 26, 1998
High resolution HLA class I typing by reference strand mediated conformation analysis (RSCA)J R Argüello, A M Little, E Bohan, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1988
[Host-graft interactions after allogenic bone marrow transplantation; choice of donor]N Alby, A Bernard, A Devergie, et al.Pageof 58